Press release
๐๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ-๐๐๐ฌ๐ข๐ฌ๐ญ๐๐ง๐ญ ๐๐๐ฉ๐ซ๐๐ฌ๐ฌ๐ข๐จ๐ง ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ, ๐๐ข๐ณ๐, ๐๐ก๐๐ซ๐ & ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค - ๐๐๐๐-
๐๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ-๐๐๐ฌ๐ข๐ฌ๐ญ๐๐ง๐ญ ๐๐๐ฉ๐ซ๐๐ฌ๐ฌ๐ข๐จ๐ง ๐๐๐ซ๐ค๐๐ญ || 2024-2031
Treatment-Resistant Depression (TRD) refers to a form of major depressive disorder (MDD) in which patients do not respond adequately to standard treatments, such as antidepressants or psychotherapy. Typically, a person is considered to have TRD when they have tried at least two different antidepressant medications, each for an adequate duration and dosage, without experiencing significant improvement in their symptoms. This condition requires more intensive treatment strategies, which may include a combination of medications, electroconvulsive therapy (ECT), or newer treatments like transcranial magnetic stimulation (TMS) or ketamine therapy.
Get a Free Sample Research PDF - https://www.datamintelligence.com/download-sample/treatment-resistant-depression-market
Key Developments:
โ August 19, 2022: The U.S. FDA approved AUVELITYโข (dextromethorphan HBr-bupropion HCl) extended-release tablets for the treatment of major depressive disorder (MDD) in adults.
โข Developed by Axsome Therapeutics, Inc., a biopharmaceutical company focused on therapies for central nervous system (CNS) disorders.
โ January 30, 2023: Otsuka Pharmaceutical Co., Ltd. submitted a Japanese application for Rexulti (brexpiprazole) as an adjunct therapy for MDD and depressive states.
โข This application is limited to patients who have not responded well to prior antidepressant therapy.
โข A phase 3 clinical trial involving 740 adult MDD patients in Japan (ages 20-64) demonstrated the safety and efficacy of brexpiprazole as an additional treatment.
Market Dynamics:
โ Developed economies have seen rapid growth in healthcare sectors due to high investments, income levels, and infrastructure development.
โ Rising cases of treatment-resistant depression (TRD) are linked to increased lung cancer cases in some regions.
โ Collaborations, acquisitions, and product launches with technological advancements are key drivers of market growth.
Market Segmentation:
By Drugs: Antipsychotics (Aripiprazole (Abilify), Brexpiprazole (Rexulti), Quetiapine (Seroquel), Olanzapine (Zyprexa), Selective Serotonin Reuptake Inhibitors (SSRIs) (Fluoxetine (Prozac), Sertraline (Zoloft), Citalopram (Celexa), Paroxetine (Paxil), Serotonin and Noradrenaline Reuptake Inhibitors (SNRIs) (Duloxetine (Cymbalta), Venlafaxine (Effexor XR), Desvenlafaxine (Pristiq), Monoamine Oxidase Inhibitors (MAOIs) (Phenelzine (Nardil), Isocarboxazid (Marplan), Others.
By Route of Administration: Oral, Injectable, Others.
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.
Get Customized Report: https://www.datamintelligence.com/customize/treatment-resistant-depression-market
Major Key Players:
โข Pfizer Inc.
โข Viatris Inc.
โข Novartis AG
โข AbbVie Inc.
โข Eli Lilly and Company
โข Otsuka America Pharmaceutical, Inc.
โข AstraZeneca
โข Camber Pharmaceuticals, Inc.
โข Biodesix
โข Validus Pharmaceuticals
*Note:
โข Additionally, I wanted to highlight that the full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted.
Related Reports:
Psychedelic Drugs Market: https://datamintelligence.com/research-report/psychedelic-drugs-market
Psychotherapeutic Drugs Market: https://datamintelligence.com/research-report/psychotherapeutic-drugs-market
Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release ๐๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ-๐๐๐ฌ๐ข๐ฌ๐ญ๐๐ง๐ญ ๐๐๐ฉ๐ซ๐๐ฌ๐ฌ๐ข๐จ๐ง ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ, ๐๐ข๐ณ๐, ๐๐ก๐๐ซ๐ & ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค - ๐๐๐๐- here
News-ID: 3656756 • Views: โฆ
More Releases from DataM Intelligence 4market Research LLP
Voice Assistant Market to Hit US$14.20 Billion by 2032, Driven by AI and IoT Exp โฆ
According to DataM Intelligence, the voice assistant market was valued at US$ 2.73 billion in 2024 and is projected to reach US$ 14.20 billion by 2032, growing at a CAGR of 22.89% during the forecast period (2025-2032). Growth is primarily driven by the proliferation of smart devices, expanding IoT ecosystems, and the shift toward voice-based human-machine interfaces. The hardware segment, led by smart speakers and voice-enabled devices, currently dominates theโฆ
North America Spatial Computing Market to Hit $260.8 Billion by 2032, Driven by โฆ
According to DataM Intelligence, the North America spatial computing market size reached US$ 58,772.07 million in 2024 and is projected to surge to US$ 260,839.20 million by 2032, representing a robust CAGR of 20.9% during the forecast period (2025-2032). Several factors are driving this strong growth. The increasing adoption of immersive technologies (AR/VR/MR) across verticals such as healthcare, manufacturing, retail, and education is unlocking new applications. Moreover, advancements in connectivityโฆ
Pharmaceutical Drying Equipment Market to Hit $10.35 Billion by 2033 - Driven by โฆ
According to DataM Intelligence, the pharmaceutical drying equipment market reached US$ 5.45 billion in 2023, increased to US$ 5.78 billion in 2024, and is projected to reach US$ 10.35 billion by 2033, growing at a CAGR of 6.7% during the forecast period (2025-2033). Market growth is propelled by the rapid expansion of the pharmaceutical and biopharmaceutical sectors, technological innovations in drying systems, and the rise in outsourcing of drug manufacturingโฆ
Triple Negative Breast Cancer Market Driven by Rising Cases and Immunotherapy Ad โฆ
According to DataM Intelligence, the Triple Negative Breast Cancer Treatment Market reached approximately US$ 0.95 billion in 2023 and is projected to reach US$ 1.66 billion by 2033, growing at a CAGR of around 6.6% during the forecast period (2025-2033). The market growth is driven by the rising global incidence of breast cancer, the aggressive nature of TNBC, and rapid advancements in immunotherapy and antibody-drug conjugates (ADCs).
Key market growth driversโฆ
More Releases for MDD
Global Depression-MDD Drugs Market Analysis By Major Manufacturers and Competiti โฆ
Global Depression-MDD Drugs Market: Driven factors and Restrictions factors
The research report encompasses a comprehensive analysis of the factors that affect the growth of the market. It includes an evaluation of trends, restraints, and drivers that influence the market positively or negatively. The report also outlines the potential impact of different segments and applications on the market in the future. The information presented is based on historical milestones and current trends,โฆ
Depression-MDD Drugs Market Size, Share, Demand Forecast Report by 2030
Global Depression-MDD Drugs Market 2022-2028 - Global Industry Size, Supply Analysis, Price Analysis, Consumption and Production, Supplier and Cost Structure Analysis
Depression-MDD Drugs Market Overview
The recent market intelligence study by the research analysts at Market Business Insights (MBI) takes a deep dive into inner operations of the global Depression-MDD Drugs Market. It thoroughly examines the market landscape to give the readers an accurate insight into the current, as well as theโฆ
Major Depressive Disorder (MDD) - Drug Pipeline Landscape, 2022
Major Depressive Disorder (MDD) also known as clinical depression, is a severe mood disorder which causes persistent or extended periods of depressed or low mood, for more than 2 weeks and a loss of interest in activities thus affecting the mood and ability to function in daily life.
To know more about Major Depressive Disorder (MDD), visit - https://www.globalinsightservices.com/reports/major-depressive-disorder-mdd-drug-pipeline-landscape-2022/
The most common causes of Major Depressive Disorder include genetics, trauma, isolation,โฆ
Major Depressive Disorder (MDD) Market In Depth Analysis 2021 To 2059Pfizer, Gla โฆ
Complete study of the global Major Depressive Disorder (MDD) market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Major Depressive Disorder (MDD) industry. Research techniques like PESTLE and Porter's Five Forces analysis have been deployed by theโฆ
U.S. Major Depressive Disorder (MDD) Market: Industry Analysis & Outlook (2018-2 โฆ
This report is available at 10% Discount for Single user License, 20% Discount for Corporate User License till 30 September 2018. To avail discount please contact at +1-888-391-5441 / sales@marketreportsonline.com.
Major Depressive Disorder Market (MDD) is a common mental illness characterized by persistent low mood that interferes with the personโs ability to eat, work, sleep and other activities. MDD is also referred to as clinical depression or recurrent depression.
Place aโฆ
MDD, Anxiety and Panic Disorder Therapeutics Market Trends and Forecast 2014 โ โฆ
The increasing prevalence of various psychological problems such as stress and sleeplessness is boosting the demand for MDD, anxiety, and panic disorder therapeutics. In its report, titled โMDD, Anxiety and Panic Disorder Therapeutics Market โ Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 โ 2020,โ Transparency Market Research (TMR) studies the various factors impacting the marketโs trajectory.
Download Exclusive Global Strategic Business Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2928
Recent patent expiries did create aโฆ
